DBV Technologies S.A. Stock Predictions

Frankfurt Stock Exchange > Healthcare > Biotechnology

Open Broker Account

1.27€

-0.140 (-9.93%)

At Close: Apr 18, 2023

Currently predicting for Thu, 25 Apr 2024

DBVA.F Predictions History

BE THE FIRST TO PREDICT

The excellent way of becoming a better trader

Easy to use
Enhance your skills
Predict as many as you like
Request predictions
Gather points

Learn to time your buy and sells

I wonder how good you are and if you can beat me?

Now it is your turn to become professional by doing what professionals do - Exercise

Best regards,

Jim - Co-founder of StockInvest.us [ See tutorial video ]

About DBV Technologies S.A.

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents, and adults. The milk-induced company is also developing Viaskin Milk that is in Phase I/II clinical t... DBVA.F Profile

Golden Star

Ticker	Date	Change	Price
LPLA	Apr 19	1.64%	$262.59
MLI	Apr 19	9.87%	$52.28
LNG	Apr 17	1.33%	$156.81
FCN	Apr 16	2.58%	$207.62
ELV	Apr 16	5.12%	$506.97
DXC	Apr 08	1.39%	$20.87
ITCI	Apr 05	8.14%	$68.44
AKR	Apr 05	6.84%	$16.53
NSIT	Apr 04	0.350%	$185.62
VSTS	Apr 04	0.638%	$18.82

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In